C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling

Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma

(2016) Xian Lin et al.   CANCER SCIENCE

Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition

(2015) Shun Li et al.   Scientific Reports

Registered report: Transcriptional amplification in tumor cells with elevated c-Myc

(2015) David Blum et al.   eLife

MicroRNA-451 induces epithelial–mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc

(2014) Dongqin Chen et al.   EUROPEAN JOURNAL OF CANCER

The risk of developing a second primary cancer in melanoma patients: A comprehensive review of the literature and meta-analysis

(2014) Saverio Caini et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Doxycycline as an Inhibitor of the Epithelial-to-Mesenchymal Transition and Vasculogenic Mimicry in Hepatocellular Carcinoma

(2014) J. Meng et al.   MOLECULAR CANCER THERAPEUTICS

VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs

(2014) Yihai Cao   Nature Reviews Endocrinology

TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling

(2014) Hong Ji et al.   Nature Communications

MYC and Transcription Elongation

(2014) P. B. Rahl et al.   Cold Spring Harbor Perspectives in Medicine

Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: A systemic review and meta-analysis

(2013) Zhifei Cao et al.   EUROPEAN JOURNAL OF CANCER

c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α

(2012) Cheng Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MYC on the Path to Cancer

(2012) Chi V. Dang   CELL

Coexpression of Bcl-2 with epithelial–mesenchymal transition regulators is a prognostic indicator in hepatocellular carcinoma

(2012) Nan Zhao et al.   MEDICAL ONCOLOGY

Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs

(2012) E.-M. E. Hedlund et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

c-Myc induction of programmed cell death may contribute to carcinogenesis

(2011) Chenguang Wang et al.   CANCER BIOLOGY & THERAPY

The HIF-1α-c-Myc pathway and tumorigenesis

(2011) Nicole Fer et al.   CELL CYCLE

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

(2011) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: A study of hepatocellular carcinoma

(2011) Tao Sun et al.   HEPATOLOGY

Molecular biology of Bax and Bak activation and action

(2010) Dana Westphal et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Guidelines for the welfare and use of animals in cancer research

(2010) P Workman et al.   BRITISH JOURNAL OF CANCER

A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients

(2010) Paolo Fardin et al.   Molecular Cancer

Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry

(2009) Tao Sun et al.   HEPATOLOGY

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Hypoxia influences linearly patterned programmed cell necrosis and tumor blood supply patterns formation in melanoma

(2009) Shiwu Zhang et al.   LABORATORY INVESTIGATION

Apoptotic signaling by c-MYC

(2008) B Hoffman et al.   ONCOGENE